| Timothy Daniel Dibble, MD | |
|
1123 N Evergreen Rd, Spokane Valley, WA 99216-1138 | |
| (509) 363-3100 | |
| (509) 363-0300 |
| Full Name | Timothy Daniel Dibble |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 1123 N Evergreen Rd, Spokane Valley, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508936212 | NPI | - | NPPES |
| CJ9109 | Other | WA | RAILROAD MEDICARE |
| 157490 | Other | WA | LABOR & INDUSTRIES |
| 805808900 | Medicaid | ID | |
| 1115443 | Medicaid | WA | |
| 125300300 | Other | WA | US DEPT OF LABOR-OWCP |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Mount Carmel Hospital | Colville, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| T Daniel Dibble Md Pc | 1254320922 | 9 |
News Archive
An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their risk of relapse or death from this disease.
Cost-effectiveness analysis should play a bigger role in the American health care system, argued a University of Chicago researcher Friday at the annual conference of the American Association for the Advancement of Science.
Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have used RNA interference in transgenic mice to silence a mutated gene that causes inherited cases of amytrophic lateral sclerosis (ALS), substantially delaying both the onset and the progression rate of the fatal motor neuron disease.
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.
› Verified 8 days ago
| Entity Name | T Daniel Dibble Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780754499 PECOS PAC ID: 1254320922 Enrollment ID: O20040507001165 |
News Archive
An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their risk of relapse or death from this disease.
Cost-effectiveness analysis should play a bigger role in the American health care system, argued a University of Chicago researcher Friday at the annual conference of the American Association for the Advancement of Science.
Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have used RNA interference in transgenic mice to silence a mutated gene that causes inherited cases of amytrophic lateral sclerosis (ALS), substantially delaying both the onset and the progression rate of the fatal motor neuron disease.
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Daniel Dibble, MD Po Box 808, Veradale, WA 99037-0808 Ph: (509) 363-3100 | Timothy Daniel Dibble, MD 1123 N Evergreen Rd, Spokane Valley, WA 99216-1138 Ph: (509) 363-3100 |
News Archive
An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their risk of relapse or death from this disease.
Cost-effectiveness analysis should play a bigger role in the American health care system, argued a University of Chicago researcher Friday at the annual conference of the American Association for the Advancement of Science.
Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have used RNA interference in transgenic mice to silence a mutated gene that causes inherited cases of amytrophic lateral sclerosis (ALS), substantially delaying both the onset and the progression rate of the fatal motor neuron disease.
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.
› Verified 8 days ago
Ryan D Burklund, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1414 N Vercler Rd, Bld 5, Spokane Valley, WA 99216 Phone: 509-385-0302 Fax: 509-385-0304 | |
Dr. Scott P. Spendlove, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1414 N Vercler Rd Ste 5, Spokane Valley, WA 99216 Phone: 206-538-6300 Fax: 206-538-6301 | |
Dr. Nathan E. Sneddon, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1123 N Evergreen Rd, Spokane Valley, WA 99216 Phone: 093-633-1005 | |
Gregory R Crisp, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1123 N Evergreen Rd, Spokane Valley, WA 99216 Phone: 509-363-3100 Fax: 509-363-0300 |